Public-registry trials using BPX-04 2% minocycline topical gel that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| Open Label Phase 2 Feasibility Study of BPX-04 Topical Minocycline Gel in Rosacea | BioPharmX, Inc. | Moderate to Severe Papulopustular Rosacea | PHASE1 / PHASE2 | 1 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →